Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Effect of Curcumin on Inflammatory Markers in Hemodialysis Patients
Sponsor: University of Guadalajara
Summary
The goal of this clinical trial is to learn if curcumin can lower the inflammation in participants with chronic kidney disease (CKD) undergoing hemodialysis (HD). The main questions it aims to answer are: Does curcumin lower can lower profinflamatory markers in participants with CKD on HD? Researchers will compare curcumin to a placebo (a look-alike substance that contains no drug) to see if curcumin works to help the treatment in participants with CKD on HD. Researchers will compare nutritional status and side effects after taking the supplement. Participants will: Take the curcumin or a placebo twice a day for 3 months Visit the clinic once every week for checkups and tests.
Official title: Effect of Curcumin on the Reduction of Cellular Inflammation Markers in Hemodialysis Patients
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2025-03-15
Completion Date
2026-12-30
Last Updated
2025-02-17
Healthy Volunteers
No
Conditions
Interventions
Curcumin (Longvida™)
patients will be suplemented during 3 months with longvida, 2 cap /8 hours
Placebo
one capsules every 8 hours during 12 weeks